New York, NY, United States of America

Weiyi Toy

This inventor holds 1 USPTO granted patent. Top assignees: Memorial Sloan Kettering Cancer Center, Stevens Institute of Technology, University of Illinois. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weiyi Toy. Retrieved from https://idiyas.com/inventor/weiyi-toy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weiyi Toy and Antiestrogen Compounds

Introduction

Weiyi Toy is an inventor based in New York, NY (US), whose work includes a patent application concerning antiestrogen compounds with potential applications in breast cancer treatment.

Latest Patents

Toy is associated with one patent: Antiestrogen compounds. The invention describes a genus of proteolysis-targeting chimeras (PROTACs)-type compounds that can act as selective estrogen receptor degraders (SERDs) and estrogen receptor antagonists. These compounds target estrogen receptor alpha (ERα) in breast cancer cells, where they may degrade or antagonize the receptor.

The compounds combine an ERα-binding ligand with a recognition motif, or degron. After binding to ERα, the degron recruits cellular components that can promote the receptor’s degradation. The compounds also exhibit antiproliferative effects and may have potential for treating breast cancer, either alone or in combination with other therapies. Toy’s reported patent count is 1 patent.

Career Highlights

Toy’s listed affiliations include Stevens Institute of Technology and Memorial Sloan Kettering Cancer Center. The patent’s focus on targeted estrogen-receptor degradation connects molecular design with a potential therapeutic approach to breast cancer.

Collaborations

Toy’s listed coworkers include Sarat Chandarlapaty and Lucia Wang. Their names are associated with the professional and research context provided for Toy.

Conclusion

Weiyi Toy’s patent on antiestrogen compounds describes a targeted approach to degrading or antagonizing ERα, with potential applications in breast cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…